Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Annals of Hematology
|
May 27, 2020
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
A Muntañola, T Baumann, A C Caballero, et al.
Bone Marrow Transplantation
|
April 21, 2001
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens
A Salar, J Sierra, M Gandarillas, et al.
The British Journal of Dermatology
|
February 24, 2012
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
Y Peñate, B Hernández-Machín, L I Pérez-Méndez, et al.
British Journal of Haematology
|
July 24, 2023
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO
A Martín García-Sancho, M Baile, G Rodríguez, et al.
Leukemia
|
December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
E Matutes, D Oscier, C Montalban, et al.
ESMO Open
|
November 26, 2025
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI
F Martin-Moro, L Bento, J Marquet, et al.
Leukemia
|
December 4, 2013
Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation
N Martínez, C Almaraz, J P Vaqué, et al.
Journal of Neuro-Oncology
|
June 12, 2020
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study
R Velasco, S Mercadal, N Vidal, et al.
Leukemia
|
August 15, 2017
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
K Karube, A Enjuanes, I Dlouhy, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Annals of Hematology
|
May 27, 2020
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
A Muntañola, T Baumann, A C Caballero, et al.
Bone Marrow Transplantation
|
April 21, 2001
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens
A Salar, J Sierra, M Gandarillas, et al.
The British Journal of Dermatology
|
February 24, 2012
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
Y Peñate, B Hernández-Machín, L I Pérez-Méndez, et al.
British Journal of Haematology
|
July 24, 2023
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO
A Martín García-Sancho, M Baile, G Rodríguez, et al.
Leukemia
|
December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
E Matutes, D Oscier, C Montalban, et al.
ESMO Open
|
November 26, 2025
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI
F Martin-Moro, L Bento, J Marquet, et al.
Leukemia
|
December 4, 2013
Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation
N Martínez, C Almaraz, J P Vaqué, et al.
Journal of Neuro-Oncology
|
June 12, 2020
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study
R Velasco, S Mercadal, N Vidal, et al.
Leukemia
|
August 15, 2017
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
K Karube, A Enjuanes, I Dlouhy, et al.
Page
of 4